AAAAAA
Results:
1-8
|
Results: 8
Authors:
Motzer, RJ
Rakhit, A
Thompson, JA
Nemunaitis, J
Murphy, BA
Ellerhorst, J
Schwartz, LH
Berg, WJ
Bukowski, RM
Citation: Rj. Motzer et al., Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-alpha 2a for patients with advanced renal cell carcinoma, J INTERF CY, 21(4), 2001, pp. 257-263
Authors:
Rakhit, A
Maguire, CT
Wakimoto, H
Gehrmann, J
Li, GK
Kelly, RA
Michel, T
Berul, CI
Citation: A. Rakhit et al., In vivo electrophysiologic studies in endothelial nitric oxide synthase (eNOS)-deficient mice, J CARD ELEC, 12(11), 2001, pp. 1295-1301
Authors:
Leyland-Jones, B
Arnold, A
Gelmon, K
Verma, S
Ayoub, JP
Seidman, A
Dias, R
Howell, J
Rakhit, A
Citation: B. Leyland-jones et al., Pharmacologic insights into the future of trastuzumab, ANN ONCOL, 12, 2001, pp. 43-47
Authors:
Motzer, RJ
Rakhit, A
Ginsberg, M
Rittweger, K
Vuky, J
Yu, R
Fettner, S
Hooftman, L
Citation: Rj. Motzer et al., Phase I trial of 40-kd branched pegylated interferon alfa-2a for patients with advanced renal cell carcinoma, J CL ONCOL, 19(5), 2001, pp. 1312-1319
Authors:
Carreno, V
Zeuzem, S
Hopf, U
Marcellin, P
Cooksley, WGE
Fevery, J
Diago, M
Reddy, R
Peters, M
Rittweger, K
Rakhit, A
Pardo, M
Citation: V. Carreno et al., A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B, J HEPATOL, 32(2), 2000, pp. 317-324
Authors:
Portielje, JEA
Kruit, WHJ
Schuler, M
Beck, J
Lamers, CHJ
Stoter, G
Huber, C
de Boer-Dennert, M
Rakhit, A
Bolhuis, RLH
Waiter, E
Citation: Jea. Portielje et al., Phase I study of subcutaneously administered recombinant human interleukin12 in patients with advanced renal cell cancer, CLIN CANC R, 5(12), 1999, pp. 3983-3989
Authors:
Zeuzem, S
Hopf, U
Carreno, V
Diago, M
Shiffman, M
Grune, S
Dudley, FJ
Rakhit, A
Rittweger, K
Yap, SH
Koff, RS
Thomas, HC
Citation: S. Zeuzem et al., A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C, HEPATOLOGY, 29(4), 1999, pp. 1280-1287
Authors:
Rakhit, A
Yeon, MM
Ferrante, J
Fettner, S
Nadeau, R
Motzer, R
Bukowski, R
Carvajal, DM
Wilkinson, VL
Presky, DH
Magram, J
Gately, MK
Citation: A. Rakhit et al., Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice, CLIN PHARM, 65(6), 1999, pp. 615-629
Risultati:
1-8
|